Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-15 | Mr. Bohlin graduated from the University of Illinois with a B.S. in Accounting and Finance in 1970. |
| 2020-04-09 | Mr. Bohlin graduated from the University of Illinois with a B.S. in Accounting and Finance in 1970. |
| 2021-04-07 | Mr. Bohlin graduated from the University of Illinois with a B.S. in Accounting and Finance in 1970. |
| 2022-04-06 | Mr. Bohlin has almost 30 years’ experience serving in executive roles at several biotechnology companies, including Constellation Pharmaceuticals, Inc., where he served as an Executive Vice President from January 2010 to his retirement in April 2012. |
| 2023-04-11 | Mr. Bohlin graduated from the University of Illinois with a B.S. in Accounting and Finance in 1970... He has served in executive roles at several biotechnology companies. |
| 2024-04-05 | Mr. Bohlin has almost 30 years of experience serving in executive roles at several biotechnology companies... Mr. Bohlin graduated from the University of Illinois with a B.S. in Accounting and Finance in 1970. |
| 2025-03-28 | Mr. Bohlin graduated from the University of Illinois with a B.S. in Accounting and Finance in 1970. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-21 | Mr. Bohlin received his B.S. in accounting and finance from The University of Illinois. We believe that Mr. Bohlin is qualified to serve on our Board because of his business and professional experience. |
| 2016-04-20 | Mr. Bohlin received his B.S. in accounting and finance from The University of Illinois. We believe that Mr. Bohlin is qualified to serve on our Board because of his business and professional experience. |
| 2017-04-27 | Mr. Bohlin received his B.S. in accounting and finance from The University of Illinois. We believe that Mr. Bohlin is qualified to serve on our Board because of his industry and board experience, including his audit committee experience, with publicly traded biopharmaceutical companies. |
| 2017-07-13 | Garen Bohlin, non-executive director |
| 2018-04-26 | Mr. Bohlin received his B.S. in accounting and finance from The University of Illinois. We believe that Mr. Bohlin is qualified to serve on our Board because of his industry and board experience, including his audit committee experience, with publicly traded biopharmaceutical companies. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22